Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aspira Pathlab & Diagnostics: Board Meeting Intimation for To Consider And Approve Audited Financial Statements Of The Company As On March 31 2024 And To Discuss Any Other Matter With The Permission Of The Chair.
News Announcement

Aspira Pathlab & Diagnostics: Board Meeting Intimation for To Consider And Approve Audited Financial Statements Of The Company As On March 31 2024 And To Discuss Any Other Matter With The Permission Of The Chair.

18-May-2024 Follow Value Research Online on Google download pdfDownload PDF Aspira Pathlab

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Financial Statements (Standalone) of the Company for the fourth quarter and year ended as on March 31 2024 and to discuss any other matter with the permission of the Chair.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds